Natasha Strydom, PhD

Title(s)Postdoctoral Scholar, Bioengineering
SchoolSchool of Pharmacy
Address1700 4th St
San Francisco CA 94158
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Drug concentration at the site of disease in children with pulmonary tuberculosis. J Antimicrob Chemother. 2022 Apr 25. Lopez-Varela E, Abulfathi AA, Strydom N, Goussard P, van Wyk AC, Demers AM, Deventer AV, Garcia-Prats AJ, van der Merwe J, Zimmerman M, Carter CL, Janson J, Morrison J, Reuter H, Decloedt EH, Seddon JA, Svensson EM, Warren R, Savic RM, Dartois V, Hesseling AC. PMID: 35468189.
      View in: PubMed   Mentions:
    2. Model-Based Efficacy and Toxicity Comparisons of Moxifloxacin for Multidrug-Resistant Tuberculosis. Open Forum Infect Dis. 2022 Mar; 9(3):ofab660. Yun HY, Chang V, Radtke KK, Wang Q, Strydom N, Chang MJ, Savic RM. PMID: 35146045; PMCID: PMC8825669.
      View in: PubMed   Mentions:
    3. Emerging Therapeutics, Technologies, and Drug Development Strategies to Address Patient Nonadherence and Improve Tuberculosis Treatment. Annu Rev Pharmacol Toxicol. 2022 01 06; 62:197-210. Garcia-Cremades M, Solans BP, Strydom N, Vrijens B, Pillai GC, Shaffer C, Thomas B, Savic RM, Garcia-Cremades M, Solans BP, Strydom N, Pillai GC, Shaffer C, Savic RM. PMID: 34591605.
      View in: PubMed   Mentions:    Fields:    
    4. Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary Tuberculosis. Antimicrob Agents Chemother. 2021 09 17; 65(10):e0050621. Ernest JP, Sarathy J, Wang N, Kaya F, Zimmerman MD, Strydom N, Wang H, Xie M, Gengenbacher M, Via LE, Barry CE, Carter CL, Savic RM, Dartois V. PMID: 34252307; PMCID: PMC8448094.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    5. Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis. PLoS Comput Biol. 2020 08; 16(8):e1008107. Fors J, Strydom N, Fox WS, Keizer RJ, Savic RM. PMID: 32810158; PMCID: PMC7480878.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant Tuberculosis. Annu Rev Pharmacol Toxicol. 2021 01 06; 61:495-516. Ernest JP, Strydom N, Wang Q, Zhang N, Nuermberger E, Dartois V, Savic RM. PMID: 32806997; PMCID: PMC7790895.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies. Antimicrob Agents Chemother. 2020 02 21; 64(3). Zhang N, Strydom N, Tyagi S, Soni H, Tasneen R, Nuermberger EL, Savic RM. PMID: 31907182; PMCID: PMC7038312.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCellsPHPublic Health
    8. Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization. PLoS Med. 2019 04; 16(4):e1002773. Strydom N, Gupta SV, Fox WS, Via LE, Bang H, Lee M, Eum S, Shim T, Barry CE, Zimmerman M, Dartois V, Savic RM. PMID: 30939136; PMCID: PMC6445413.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    Natasha's Networks
    Concepts (43)
    Derived automatically from this person's publications.
    Co-Authors (3)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department